课题基金 / 基金详情

Pseudopteroxazole and Related Antitubercular Agents

Pseudopteroxazole and Related Antitubercular Agents
拟蝶恶唑及相关抗结核药
批准号:
7151457
负责人:
MICHAEL HARMATA
金额:
$23.88万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-12-01 至 2008-11-30

项目摘要

项目成果

MICHAEL HARMATA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goals of this work are to develop syntheses of antitubercular agents based on natural product leads. This will involve the total synthesis of the natural products pseudopteroxazole, seco-pseudopteroxazole, erogorgiaene, ileabethin, elisapterosin B and elisabethin A. Testing of targets and intermediates will be performed by the Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF). A unifying methodology will be developed in pursuing these goals. This involves the synthesis of enantiomerically pure benzothiazines through the intramolecular, stereoselective addition of sulfoximine carbanions to unsaturated esters. The development of this methodology will be coupled with aspects of other new chemistry to achieve the synthetic goals. Of particular importance will be the development of a stereoselective, intramolecular radical ring closure reaction as a means of establishing a six-membered ring. Two approaches to this general type of process will be explored. Benzothiazine chemistry will be further developed, particularly in the context of the synthesis of elisabethin A, during which the study of benzothiazine carbanions as nucleophiles in Michael addition reactions will be undertaken. The compounds to be prepared in this study will contribute to the goal of developing chemotherapeutics for tuberculosis. Since the targets are related to pseudopterosins, compounds with potent analgesic and antiinflammatory properties, the work will have an impact in this area as well. More generally, the methodology to be developed should have extremely broad impact, as it can be applied to the generation of stereogenic centers in a large number of compounds of biological and medicinal interest.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.tetlet.2010.11.070
发表时间: 2011-01-26
期刊: TETRAHEDRON LETTERS
影响因子: 1.8
作者: [Chen, Yugang, Ying, Weijiang, Harmata, Michael]
通讯作者: Harmata, Michael
DOI: 10.1021/ol701863y
发表时间: 2007
期刊: Organic letters
影响因子: 5.2
作者: [Harmata,Michael, Chen,Yugang, Barnes,CharlesL]
通讯作者: Barnes,CharlesL
DOI: 10.1021/jo900151d
发表时间: 2009
期刊: The Journal of organic chemistry
影响因子: --
作者: [Harmata,Michael, Rayanil,Kanok-on, Espejo,VinsonR, Barnes,CharlesL]
通讯作者: Barnes,CharlesL
Preparation of S-2-halophenyl-2,1-benzothiazines.
S-2-卤代苯基-2,1-苯并噻嗪的制备。
DOI: 10.1016/j.tet.2021.131991
发表时间: 2021
期刊: Tetrahedron
影响因子: 2.1
作者: [Garimalla,Aswin, Harmata,Michael]
通讯作者: Harmata,Michael
7
    Pseudopteroxazole and Related Antitubercular Agents
    • 批准号:
      6863274
    • 项目类别:
    • 资助金额:
      $27.71万
    • 财政年份:
      2004
    • 负责人:
      MICHAEL HARMATA
    • 依托单位:
    Pseudopteroxazole and Related Antitubercular Agents
    • 批准号:
      6986743
    • 项目类别:
    • 资助金额:
      $24.61万
    • 财政年份:
      2004
    • 负责人:
      MICHAEL HARMATA
    • 依托单位:
    BENZANNULATION APPROACH TO BIARYL ETHERS
    • 批准号:
      6386476
    • 项目类别:
    • 资助金额:
      $17.18万
    • 财政年份:
      1999
    • 负责人:
      MICHAEL HARMATA
    • 依托单位:
    ARENE-FURAN PHOTOCYCLOADDITION REACTION
    • 批准号:
      3040463
    • 项目类别:
    • 资助金额:
      $0.86万
    • 财政年份:
      1986
    • 负责人:
      MICHAEL HARMATA
    • 依托单位:
    海外基金